Don't want ads? Subscribe or login now.

Jury Awards Mallinckrodt $9.5M In Nitric Oxide Patent Suit

By Adam Lidgett · September 12, 2025, 9:11 PM EDT

A Delaware federal jury awarded Mallinckrodt Pharmaceuticals almost $9.5 million on Friday, finding that French industrial gas company Airgas Healthcare infringed patents covering its inhaled nitric oxide treatment....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Verdict

Case Information

Case Title

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Case Number

1:22-cv-01648

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

December 30, 2022

Recent Articles By Adam

September 08, 2025
Oura Domestic Labor Investment Won Import Ban, ITC Says
September 02, 2025
Gilead Rival Agrees Not To Sell Generic HIV Drug For Now
August 25, 2025
Oura Gets ITC To Bar Infringing Smart Ring Imports
August 07, 2025
Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents
July 15, 2025
Patent Fight Over Xtandi Erupts Anew Before RFK Jr.
July 15, 2025
PTAB Knocks Out Claims In 3 Nasal Airway Patents
July 08, 2025
Biosimilars Industry Group Backs Interchangeability Bill
June 18, 2025
FDA Dodges Suit Over Ozempic, Wegovy Listing
June 03, 2025
Patent Deals Accelerate Access To Generics, Drug Group Says
April 11, 2025
Foreign Cos. Say Anti-Choking Device Patent Is Invalid